For research use only. We do not sell to patients.
Gilteritinib-d8
CAS No. : 2377109-74-3
Biological Activity：Gilteritinib-d8 is deuterium labeled Gilteritinib. Gilteritinib (ASP2215) is a potent and ATP-competitive FLT3/AXL inhibitor with IC50s of 0.29 nM/0.73 nM, respectively.
Research Area：Cancer
Targets：FLT3|TAM Receptor
Related Small Molecules:AT9283;(E/Z)-Zotiraciclib;Crotonoside;Axl-IN-5;PROTAC Axl Degrader 2;FLT3-IN-13;PDGFRα/FLT3-ITD-IN-2;FLT3/CDK4-IN-1;UNC2250;HP1142;ENMD-2076 Tartrate;ATH686;AZD2932;R916562;AKN-028 acetate;XL092;FLT3-IN-3;UNC2025 hydrochloride;Tandutinib;Axl-IN-3;PF 477736;(R)-3-Hydroxy Midostaurin;BSc5371;UNC1062;Bemcentinib;OTS447
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
